The pitfall of active inflammation during surveillance colonoscopy in inflammatory bowel disease patients

Recruiting

• Conditions: colitis; inflammatory bowel disease (IBD); 10017969; 10017991; 10017998

• Registration Number: NL-OMON32200
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Patients diagnosed with either ulcerative colitis or Crohn???s disease by established criteria scheduled for surveillance colonoscopy between April 1, 2008 and March 31, 2009 in the Erasmus Medical Center will be entered into this study.

Exclusion Criteria

Exclusion criteria are: diabetes, pregnancy, hypertension and known adverse reactions on earlier use of Prednisone.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary study outcome is presence of histological inflammation of the mucosa</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary study paramteres are presence of other pathologic findings during<br /><br>endoscopy and/or in the pathology report and the management of these<br /><br>pathological findings. Patient characteristics that will furthermore be used in<br /><br>the analysis are demographic factors, like age and sex and disease<br /><br>characteristics like disease duration, activity and course as well as<br /><br>medication use. </p><br>